arBtrage CAPITALIZING MARKETS checking… Sign in

Fate Therapeutics, Inc.

FATE Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.98
▼ -10.4% Today
as of Jun 7, 07:14 ET
Last 30 days +52.31% Apr 28 → Jun 05
$1.11 $1.58 $2.04 $2.50 $2.97 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.15
High
$2.19
Low
$1.94
Volume
$4M
Avg Vol
$2M
Mkt Cap
$307M
P/E (TTM)
Beta
52w High
$2.88
52w Low
$0.91
Div Yield
Shares Out
$116M

Overview

52-week range
$0.91
$2.88
54% of range
Avg surprise (last 2)
+14.1%
Avg reaction (last 2)
-5.7%
0% positive
Latest IV / EM
164%
EM ±22.7% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.54$-0.47$-0.40$-0.33$-0.26 Actual $-0.54Actual $-0.46Actual $-0.47Actual $-0.33Actual $-0.40Actual $-0.32Est $-0.39Actual $-0.29Actual $-0.27Actual $-0.26Est $-0.29 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-48M$-34M$-20M$-7M$7M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.26 $-0.29 +10.3% +18.8% -4.9% earnings
Tue Sep 30, 2025Sep 2025 $-0.27 financials
Mon Jun 30, 2025Jun 2025 $-0.29 financials
Tue May 13, 2025Mar/2025 $-0.32 $-0.39 +17.9% -6.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.40 financials
Sun Jun 30, 2024Jun 2024 $-0.33 financials
Sun Mar 31, 2024Mar 2024 $-0.47 financials
Sat Sep 30, 2023Sep 2023 $-0.46 financials
Fri Jun 30, 2023Jun 2023 $-0.54 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$1M$2M$2M$2M$3M$7M
Cost of revenue
Gross profit
Operating income$-33M$-35M$-37M$-41M$-52M$-45M
Net income$-31M$-32M$-34M$-38M$-48M$-38M
EPS (diluted)$-0.26$-0.27$-0.29$-0.32$-0.40$-0.33

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$40M$47M$41M$41M$45M$36M$38M$37M
Inventory
Total current assets$180M$209M$221M$230M$248M$292M$310M$319M
Total assets$285M$319M$344M$372M$399M$441M$495M$529M
Long-term debt
Total liabilities
Total equity$180M$207M$234M$261M$288M$319M$362M$397M

Implied volatility — last 90 days

159%161%164%166%169% Jun 07 — IV 164% · EM ±22.7%

Sector peers